Subscribe To
It's time to be bullish on palantir
Palantir has continued its expansion into the healthcare and biotechnology sector, by joining forces with Dewpoint Therapeutics....
December 24, 2021, 10:45 am
It's time to be bullish on palantir
Palantir has continued its expansion into the healthcare and biotechnology sector, by joining forces with Dewpoint Therapeutics....
December 24, 2021, 10:45 am
It's time to be bullish on palantir
Palantir has continued its expansion into the healthcare and biotechnology sector, by joining forces with Dewpoint Therapeutics....
December 24, 2021, 10:45 am
Josh brown on biotech: i really don't think there will be any activity on drug prices next year
The "Halftime" crew discuss whether investors should position themselves in biotech in 2022....
December 23, 2021, 1:43 pm
Josh brown on biotech: i really don't think there will be any activity on drug prices next year
The "Halftime" crew discuss whether investors should position themselves in biotech in 2022....
December 23, 2021, 1:43 pm
Josh brown on biotech: i really don't think there will be any activity on drug prices next year
The "Halftime" crew discuss whether investors should position themselves in biotech in 2022....
December 23, 2021, 1:43 pm
Novartis eyes up to $1.5 billion for gene therapy firm
The prize Novartis has its eyes on is, well, eyes. The Swiss healthcare giant announced Wednesday it's buying British ...
December 22, 2021, 9:00 pm
Novartis eyes up to $1.5 billion for gene therapy firm
The prize Novartis has its eyes on is, well, eyes. The Swiss healthcare giant announced Wednesday it's buying British ...
December 22, 2021, 9:00 pm
Novartis eyes up to $1.5 billion for gene therapy firm
The prize Novartis has its eyes on is, well, eyes. The Swiss healthcare giant announced Wednesday it's buying British ...
December 22, 2021, 9:00 pm
The bad investment company launches flagship etf
On Wednesday, The BAD Investment Company announced the launch of the BAD ETF (NYSE: BAD). The indexed large-cap fund is designed to offer investors...
December 22, 2021, 1:20 pm
The bad investment company launches flagship etf
On Wednesday, The BAD Investment Company announced the launch of the BAD ETF (NYSE: BAD). The indexed large-cap fund is designed to offer investors...
December 22, 2021, 1:20 pm
The bad investment company launches flagship etf
On Wednesday, The BAD Investment Company announced the launch of the BAD ETF (NYSE: BAD). The indexed large-cap fund is designed to offer investors...
December 22, 2021, 1:20 pm
Celyad oncology announces january 2022 conference schedule
MONT-SAINT-GUIBERT, Belgium, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company fo...
December 22, 2021, 1:00 am
Celyad oncology announces january 2022 conference schedule
MONT-SAINT-GUIBERT, Belgium, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company fo...
December 22, 2021, 1:00 am
Celyad oncology announces january 2022 conference schedule
MONT-SAINT-GUIBERT, Belgium, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company fo...
December 22, 2021, 1:00 am
Sanofi in $1 billion deal to buy u.s.-based amunix pharma
Drugmaker Sanofi SA will buy Amunix Pharmaceuticals Inc for an upfront payment of about $1 billion, marking the latest acquisition by the French drugm...
December 21, 2021, 1:12 am
Sanofi in $1 billion deal to buy u.s.-based amunix pharma
Drugmaker Sanofi SA will buy Amunix Pharmaceuticals Inc for an upfront payment of about $1 billion, marking the latest acquisition by the French drugm...
December 21, 2021, 1:12 am
Sanofi in $1 billion deal to buy u.s.-based amunix pharma
Drugmaker Sanofi SA will buy Amunix Pharmaceuticals Inc for an upfront payment of about $1 billion, marking the latest acquisition by the French drugm...
December 21, 2021, 1:12 am
biotech etfs that outperformed last week
biotech ETFs was the biggest gainer last week....
December 20, 2021, 1:46 pm
biotech etfs that outperformed last week
biotech ETFs was the biggest gainer last week....
December 20, 2021, 1:46 pm